Cas:183608-47-1 5-Bromo-N-methoxy-N-methylnicotinamide manufacturer & supplier

Chemical Name:5-Bromo-N-methoxy-N-methylnicotinamide

CAS.NO:183608-47-1

Synonyms:5-bromo-N-methoxy-N-methylpyridine-3-carboxamide

Molecular Formula:C₈H₉BrN₂O₂

Molecular Weight:245.07300

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:42.43000

Exact Mass:243.98500

LogP:1.47750

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-bromo-N-methoxy-N-methylpyridine-3-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-N-methoxy-N-methylpyridine-3-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-N-methoxy-N-methylpyridine-3-carboxamide Use and application,5-bromo-N-methoxy-N-methylpyridine-3-carboxamide technical grade,usp/ep/jp grade.

Related News: McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 2-amino-1-(2-carboxy-ethyl)-6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid manufacturers The inhaled version was also found to trigger neutralising antibodies and T cell responses after one dose. benzoic acid,2,2-bis(hydroxymethyl)butyl acetate suppliers Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 2-Fluoro-N-(4-fluorophenyl)benzamide vendor & factory.